Buy or sell Metabolon stock pre IPO via an EquityZen fund
EquityZen is a marketplace for shares of proven pre IPO tech companies

Metabolon Stock
Metabolon develops analytical methods and software for biomarker discovery by using metabolomics.
About Metabolon Stock
Metabolon is a technology company, develops analytical methods and software for biomarker discovery using metabolomics. It offers a biochemical profiling platform that analyzes and identifies biochemicals in the research of pharmaceutical, biotech, agriculture, cosmetic, and consumer products. Metabolon provides a unique, real-time fingerprint of biological system to reveal novel discoveries and realize the promise of precision medicine. The company can deliver an instantaneous snapshot of the entire physiology of a living being at a discreet point in time, as well as identify changes in that system brought about the impact of the disease, medical intervention, diet, or the environment. This deep and comprehensive view of the metabolome provides biological insights that cannot be revealed through any other research methodology, enabling life sciences researchers and drug developers to discover answers to some of biology’s most difficult questions. Metabolon was founded in 2000 and headquartered in Durham, North Carolina.
Funding History
August 2003 | $4.0M |
---|---|
October 2004 | $5.0M |
January 2006 | $8.0M |
March 2008 | $3.1M |
October 2009 | $6.2M |
December 2009 | $6.0M |
August 2011 | $13.1M |
January 2014 | $15.0M |
March 2015 | $5.0M |
August 2016 | $15.0M |
August 2018 | $7.3M |
August 2020 | $72.0M |
Management
Chief Business Officer
Rohan F. Hastie
Chief Executive Officer
Rohan F. Hastie
Board of Directors
Tom Caskey
Member of Scientific Advisory Board
Paul Schimmel
Scientific Advisory Board
Arul Chinnaiyan
Board of Directors
John Oxaal
Board of Director
Christopher W. Kersey
Chief Scientific Officer
Rangaprasad Sarangarajan
Board of Directors
Santo Costa
Interim Chief Financial Officer
John T. Kurtzweil
Board of Directors
Rudy Howard
Chief Financial Officer
Gerry Haines
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase